In general, this study was designed to investigate the possible utilization of midazolam anesthesia to recover cisplatin-sensitivity for NSCLC treatment, and explored the involvement of the miR-194-5p/HOOK3 axis in modulating this process. This evidence concerns the gene HOOK3 and non-small cell lung carcinoma.